• Wolverine Blend BPC-157 TB-500 lyophilised research peptide blend vial – Dubai Peptides UAE
1 1

Omni Peptides

Wolverine Blend

Dhs. 400.00 AED
Dhs. 400.00 AED
Sale Sold out
CHOOSE YOUR FORMAT

Size
Lyophilised & sealed vials
Independent COA · ≥99% purity
Cold-chain dispatch · same day Dubai
Discreet · unbranded outer packaging

Wolverine Blend (also known as the Wolverine Stack or BPC-157/TB-500 Blend) is a synthetic peptide combination consisting of BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4), typically formulated in a single vial (e.g., 10mg BPC-157 + 10mg TB-500 or similar ratios). This research formulation has gained significant attention in preclinical and regenerative medicine investigations for its synergistic potential to accelerate tissue repair, reduce inflammation, and support recovery processes. The nickname "Wolverine" draws from the Marvel character's rapid healing abilities, reflecting the observed complementary actions of the two peptides in animal models. Preliminary and advanced preclinical studies on the individual components and their combination suggest enhanced effects on angiogenesis, cell migration, extracellular matrix remodeling, and anti-inflammatory pathways. Researchers utilize Wolverine Blend in laboratory and animal models to explore mechanisms of musculoskeletal, soft tissue, and systemic regeneration, particularly in injury, overuse, and age-related degeneration contexts. As a research-grade compound, Wolverine Blend is intended exclusively for in vitro and animal studies. Scientists value its combined profile, which may offer broader regenerative coverage than either peptide alone, providing insights into multi-pathway peptide synergy in tissue restoration.

Composition
BPC-157C₆₂H₉₈N₁₆O₂₂·1419.5
TB-4C₂₁₂H₃₅₀N₅₆O₇₈S·4963.5
Sequences
BPC-157Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
TB-4Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser

Research Applications

01 Musculoskeletal and Soft Tissue Regeneration
Preclinical models demonstrate that the BPC-157/TB-500 combination markedly accelerates healing of muscles, tendons, ligaments, and joints. It enhances biomechanical recovery, collagen organization, and structural integrity in transection, crush, and overuse injury models, often showing superior outcomes compared to single-peptide administration.
02 Injury Recovery and Wound Healing
Investigations highlight accelerated closure of cutaneous, surgical, and deep-tissue wounds, with reduced scar formation and improved granulation tissue quality. The blend supports re-epithelialization, cell proliferation, and resolution of inflammation in various trauma and post-surgical paradigms.
03 Anti-Inflammatory and Cytoprotective Effects
The combination potently downregulates pro-inflammatory cytokines, mitigates oxidative stress, and promotes a reparative microenvironment. Studies explore its efficacy in models of chronic inflammation, tendonitis, arthritis, and systemic inflammatory insults.
04 Angiogenesis and Vascular Support
Synergistic activation of VEGF pathways, endothelial cell migration, and new vessel formation facilitates nutrient delivery and oxygenation in ischemic or poorly vascularized tissues, enhancing overall regenerative potential.
05 Broader Systemic and Protective Effects
Research suggests benefits in gastrointestinal protection (from BPC-157's gastric origin), cardiac tissue support, and general recovery from physical stress. Emerging data probe its role in age-related decline, overuse syndromes, and multi-tissue repair scenarios.

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.

— About this compound

Wolverine Blend is a combined regenerative peptide blend.

Wolverine Blend (also known as the Wolverine Stack or BPC-157/TB-500 Blend) is a synthetic peptide combination consisting of BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4), typically formulated in a single vial (e.g., 10mg BPC-157 + 10mg TB-500 or similar ratios). This research formulation has gained significant attention in preclinical and regenerative medicine investigations for its synergistic potential to accelerate tissue repair, reduce inflammation, and support recovery processes. The nickname "Wolverine" draws from the Marvel character's rapid healing abilities, reflecting the observed complementary actions of the two peptides in animal models. Preliminary and advanced preclinical studies on the individual components and their combination suggest enhanced effects on angiogenesis, cell migration, extracellular matrix remodeling, and anti-inflammatory pathways. Researchers utilize Wolverine Blend in laboratory and animal models to explore mechanisms of musculoskeletal, soft tissue, and systemic regeneration, particularly in injury, overuse, and age-related degeneration contexts. As a research-grade compound, Wolverine Blend is intended exclusively for in vitro and animal studies. Scientists value its combined profile, which may offer broader regenerative coverage than either peptide alone, providing insights into multi-pathway peptide synergy in tissue restoration.

Related Reading

Journal Wolverine Blend (BPC-157 + TB-500): What the Research Shows →
Research Brief Wolverine Blend →

Two compounds, one formulation.

COMPOSITION · 2 COMPOUNDS
BPC-157C₆₂H₉₈N₁₆O₂₂
1419.5 g/mol ▾
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
TB-4C₂₁₂H₃₅₀N₅₆O₇₈S
4963.5 g/mol ▾
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
COMBINED WEIGHT ~6,383 g/mol (equal parts)

Research Applications

Where researchers apply it.

01 Musculoskeletal and Soft Tissue Regeneration
Preclinical models demonstrate that the BPC-157/TB-500 combination markedly accelerates healing of muscles, tendons, ligaments, and joints. It enhances biomechanical recovery, collagen organization, and structural integrity in transection, crush, and overuse injury models, often showing superior outcomes compared to single-peptide administration.
02 Injury Recovery and Wound Healing
Investigations highlight accelerated closure of cutaneous, surgical, and deep-tissue wounds, with reduced scar formation and improved granulation tissue quality. The blend supports re-epithelialization, cell proliferation, and resolution of inflammation in various trauma and post-surgical paradigms.
03 Anti-Inflammatory and Cytoprotective Effects
The combination potently downregulates pro-inflammatory cytokines, mitigates oxidative stress, and promotes a reparative microenvironment. Studies explore its efficacy in models of chronic inflammation, tendonitis, arthritis, and systemic inflammatory insults.
04 Angiogenesis and Vascular Support
Synergistic activation of VEGF pathways, endothelial cell migration, and new vessel formation facilitates nutrient delivery and oxygenation in ischemic or poorly vascularized tissues, enhancing overall regenerative potential.
05 Broader Systemic and Protective Effects
Research suggests benefits in gastrointestinal protection (from BPC-157's gastric origin), cardiac tissue support, and general recovery from physical stress. Emerging data probe its role in age-related decline, overuse syndromes, and multi-tissue repair scenarios.

— Verified & Documented

Every vial is backed by a Certificate of Analysis.

Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.

Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.

>99%
HPLC Purity
MS
Identity Confirmed
Certificate of Analysis
WOLVERINE BLEND · BATCH TB1010-0928 · QC RELEASE
PASS
IdentityConfirmed
Mass23.06 mg
Purity>99%
AppearanceWhite Lyophilised
LabJanoshik Analytical (Independant)
Date07/10/25

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.